(Q54334681)

English

Design of new selective inhibitors of cyclooxygenase-2 by dynamic assembly of molecular building blocks.

scientific article published in May 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/11394738

Design of new selective inhibitors of cyclooxygenase-2 by dynamic assembly of molecular building blocks. (English)

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/11394738

molecular design

0 references

2

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/11394738

author name string

J Zhu

1

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/11394738

H Fan

3

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/11394738

H Liu

4

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/11394738

Y Shi

5

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/11394738

publication date

1 May 2001

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/11394738

Journal of Computer - Aided Molecular Design

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/11394738

15

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/11394738

5

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/11394738

447-463

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/11394738

https://scigraph.springernature.com/pub.10.1023/a:1011114307711

0 references

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/11394738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CONCERTS: dynamic connection of fragments as an approach to de novo ligand design

1 reference

https://pubmed.ncbi.nlm.nih.gov/11394738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

1 reference

https://pubmed.ncbi.nlm.nih.gov/11394738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site

1 reference

https://pubmed.ncbi.nlm.nih.gov/11394738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functionality maps of binding sites: a multiple copy simultaneous search method

1 reference

https://pubmed.ncbi.nlm.nih.gov/11394738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases

1 reference

https://pubmed.ncbi.nlm.nih.gov/11394738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The computer program LUDI: a new method for the de novo design of enzyme inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11394738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure-based ligand design by dynamically assembling molecular building blocks at binding site.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11394738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators

1 reference

https://pubmed.ncbi.nlm.nih.gov/11394738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/11394738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11394738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Solvent accessible surface area and excluded volume in proteins. Analytical equations for overlapping spheres and implications for the hydrophobic effect.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11394738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimization by Simulated Annealing

1 reference

https://pubmed.ncbi.nlm.nih.gov/11394738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin endoperoxide synthases-1 and -2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11394738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and biological evaluation of 3,4-diaryloxazolones: A new class of orally active cyclooxygenase-2 inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11394738

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1011114307711

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/11394738

DBLP publication ID

journals/jcamd/ZhuYFLS01

1 reference

DBLP Dataset 2021-01-02

28 January 2021

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/11394738

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54334681&oldid=1391358875"